Benefit–Risk Analysis of Glatiramer Acetate for Relapsing-Remitting and Clinically Isolated Syndrome Multiple Sclerosis (Q22252291)
Jump to navigation
Jump to search
scientific article
- Benefit-risk analysis of glatiramer acetate for relapsing-remitting and clinically isolated syndrome multiple sclerosis
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Benefit–Risk Analysis of Glatiramer Acetate for Relapsing-Remitting and Clinically Isolated Syndrome Multiple Sclerosis |
scientific article |
|
Statements
Benefit–Risk Analysis of Glatiramer Acetate for Relapsing-Remitting and Clinically Isolated Syndrome Multiple Sclerosis (English)
0 references
1 reference
Nawab Qizilbash
1 reference
Rainel Sanchez-de la Rosa
1 reference
January 2012
0 references
34
0 references
1
0 references
159-176.e5
0 references